The European Federation of Pharmaceutical Industries and Associations (EFPIA), headquartered in Belgium, represents the pharmaceutical industry across Europe. Founded in 1978, EFPIA plays a pivotal role in advocating for the interests of its members, which include leading pharmaceutical companies and national associations. The organisation focuses on key areas such as research and development, access to medicines, and healthcare policy.
With a commitment to innovation, EFPIA supports initiatives that enhance patient access to high-quality treatments while promoting sustainable healthcare systems. Its unique position as a bridge between the pharmaceutical industry and European policymakers enables it to influence critical discussions on health and medicine. Notable achievements include significant contributions to public health and the advancement of regulatory frameworks that benefit both patients and the industry.
+2 vs industry average
Efpia’s score of 27 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Efpia?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Other Services has below-average carbon intensity
Industry performance
The Other Services industry has reduced its overall emissions by 5% since 2019
Emissions trajectory 2020 – 2025
Reported emissions
Scope 3 accounts for ••• of total emissions.
Efpia's reported carbon emissions
In 2022, Efpia reported total carbon emissions of approximately 97.1 billion kg CO2e, comprising 8.9 billion kg CO2e from Scope 1, 4.9 billion kg CO2e from Scope 2, and 97.1 billion kg CO2e from Scope 3 emissions. The organisation has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 emissions by 46% by 2030 compared to a 2019 baseline, with a long-term goal of achieving a 95% reduction by 2040. These targets reflect Efpia's commitment to addressing climate change and reducing its carbon footprint in the pharmaceutical industry.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Efpia’s Climate Goals (2030 & 2050)
4 goals2040
95% reduction in Scope 1
We aim to reduce our company (Scope 1 & 2) emissions by 46% by 2030 compared to a 2019 baseline; as an interim milestone to reduce our compa…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 4 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Efpia
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project